Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I D R Arnott

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Alimentary Pharmacology & Therapeutics|October 15, 2013
A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysisN A Kennedy, E Rhatigan, I D R Arnott, et al.
Clinical and Experimental Immunology|March 11, 2004
Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutationsL J Walker, M C Aldhous, H E Drummond, et al.
Inflammatory Bowel Diseases|July 21, 2009
Lack of association between cervical dysplasia and IBD: a large case-control studyC W Lees, J Critchley, N Chee, et al.
Genes and Immunity|June 20, 2008
Detailed assessment of NOD2/CARD15 exonic variation in inflammatory bowel disease in Scotland: implications for disease pathogenesisR K Russell, H E Drummond, D C Wilson, et al.
Alimentary Pharmacology & Therapeutics|July 20, 2007
A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitisC W Lees, D Heys, G T Ho, et al.
Genes and Immunity|June 11, 2004
NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe?I D R Arnott, E R Nimmo, H E Drummond, et al.
Inflammatory Bowel Diseases|November 20, 2009
Magnetic resonance follow-through imaging for evaluation of disease activity in ileal Crohn's disease: an observational, retrospective cohort studyC A Parisinos, V E D McIntyre, T Heron, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 31, 2009
Anti-Saccharomyces cerevisiae antibodies status is associated with oral involvement and disease severity in Crohn diseaseR K Russell, B Ip, M C Aldhous, et al.
Alimentary Pharmacology & Therapeutics|January 10, 2009
The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-upC W Lees, A I Ali, A I Thompson, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Alimentary Pharmacology & Therapeutics|October 15, 2013
A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysisN A Kennedy, E Rhatigan, I D R Arnott, et al.
Clinical and Experimental Immunology|March 11, 2004
Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutationsL J Walker, M C Aldhous, H E Drummond, et al.
Inflammatory Bowel Diseases|July 21, 2009
Lack of association between cervical dysplasia and IBD: a large case-control studyC W Lees, J Critchley, N Chee, et al.
Genes and Immunity|June 20, 2008
Detailed assessment of NOD2/CARD15 exonic variation in inflammatory bowel disease in Scotland: implications for disease pathogenesisR K Russell, H E Drummond, D C Wilson, et al.
Alimentary Pharmacology & Therapeutics|July 20, 2007
A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitisC W Lees, D Heys, G T Ho, et al.
Genes and Immunity|June 11, 2004
NOD2/CARD15, TLR4 and CD14 mutations in Scottish and Irish Crohn's disease patients: evidence for genetic heterogeneity within Europe?I D R Arnott, E R Nimmo, H E Drummond, et al.
Inflammatory Bowel Diseases|November 20, 2009
Magnetic resonance follow-through imaging for evaluation of disease activity in ileal Crohn's disease: an observational, retrospective cohort studyC A Parisinos, V E D McIntyre, T Heron, et al.
Journal of Pediatric Gastroenterology and Nutrition|January 31, 2009
Anti-Saccharomyces cerevisiae antibodies status is associated with oral involvement and disease severity in Crohn diseaseR K Russell, B Ip, M C Aldhous, et al.
Alimentary Pharmacology & Therapeutics|January 10, 2009
The safety profile of anti-tumour necrosis factor therapy in inflammatory bowel disease in clinical practice: analysis of 620 patient-years follow-upC W Lees, A I Ali, A I Thompson, et al.
Pageof 2